Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma. | World J Surg Oncol | 2022 | 35065633 | PubTator, text mining | PubMed |
| Scaffolding of Mitogen-Activated Protein Kinase Signaling by β-Arrestins. | Int J Mol Sci | 2022 | 35055186 | PubTator, text mining | PubMed |
| A Structure is Worth a Thousand Words: New Insights for RAS and RAF Regulation. | Cancer Discov | 2022 | 35046094 | PubTator, text mining | PubMed |
| Acetylation-dependent regulation of BRAF oncogenic function. | Cell Rep | 2022 | 35045286 | PubTator, text mining | PubMed |
| Upregulation of the novel lncRNA U731166 is associated with migration, invasion and vemurafenib resistance in melanoma. | J Cell Mol Med | 2022 | 35040264 | PubTator, text mining | PubMed |
| NETME: on-the-fly knowledge network construction from biomedical literature. | Appl Netw Sci | 2022 | 35013714 | PubTator, text mining | PubMed |
| Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders. | Transl Psychiatry | 2022 | 35013130 | PubTator, text mining | PubMed |
| Temporal Quantitative Phosphoproteomics Profiling of Interleukin-33 Signaling Network Reveals Unique Modulators of Monocyte Activation. | Cells | 2022 | 35011700 | PubTator, text mining | PubMed |
| Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011-2020): Current Status and Future Prospects. | Molecules | 2022 | 35011562 | PubTator, text mining | PubMed |
| Repeated treatments of Capan-1 cells with PARP1 and Chk1 inhibitors promote drug resistance, migration and invasion. | Cancer Biol Ther | 2022 | 35000525 | PubTator, text mining | PubMed |
| HOMELETTE: a unified interface to homology modelling software. | Bioinformatics | 2022 | 34954790 | PubTator, text mining | PubMed |
| Targeting KRAS mutant lung cancer: light at the end of the tunnel. | Mol Oncol | 2022 | 34951114 | PubTator, text mining | PubMed |
| Progressive nodular histiocytosis in a 9-year-old boy treated with cobimetinib. | Pediatr Dermatol | 2022 | 34935192 | PubTator, text mining | PubMed |
| PKM2 Is Essential for Bladder Cancer Growth and Maintenance. | Cancer Res | 2022 | 34903602 | PubTator, text mining | PubMed |
| Detection of gene mutations and gene-gene fusions in circulating cell-free DNA of glioblastoma patients: an avenue for clinically relevant diagnostic analysis. | Mol Oncol | 2022 | 34875133 | PubTator, text mining | PubMed |
| Genomic comparisons between hepatocarcinogenic and non-hepatocarcinogenic organophosphate insecticides in the mouse liver. | Toxicology | 2022 | 34813904 | PubTator, text mining | PubMed |
| Long non-coding RNAs are involved in alternative splicing and promote cancer progression. | Br J Cancer | 2022 | 34750493 | PubTator, text mining | PubMed |
| Vertical Inhibition of the RAF-MEK-ERK Cascade Induces Myogenic Differentiation, Apoptosis, and Tumor Regression in H/NRASQ61X Mutant Rhabdomyosarcoma. | Mol Cancer Ther | 2022 | 34737198 | PubTator, text mining | PubMed |
| Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation. | Mol Omics | 2022 | 34709266 | PubTator, text mining | PubMed |
| Can miRNAs be useful biomarkers in improving prognostic stratification in endometrial cancer patients? An update review. | Int J Cancer | 2022 | 34706070 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=29